Comparison of Effects of a Thrombin-Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial

Table 4

Incidence of events for safety analysis.

Event	TXA ()	Floseal ()	Control ()	value
Up to POD 14
Ecchymosis	16/34 (47.1%)	20/34 (58.8%)	23/35 (65.7%)	0.286
Swelling	1/34 (2.9%)	1/34 (2.9%)	2/35 (5.7%)	0.788
Wound healing	34/34 (100%)	33/34 (97.1%)	33/35 (94.3%)	0.369
Any deep-vein thrombosis	0/34 (0%)	0/34 (0%)	0/35 (0%)	1.000
Up to 3 months
Pulmonary embolism	0/34 (0%)	0/34 (0%)	0/35 (0%)	1.000
Symptomatic deep-vein thrombosis	0/34 (0%)	0/34 (0%)	0/35 (0%)	1.000
Return to OR because of wound complication	0/34 (0%)	0/34 (0%)	0/35 (0%)	1.000
Death	0/34 (0%)	0/34 (0%)	0/nny (0%)	1.000

POD: postoperative day; OR: operating room.